Publication:
Partial versus radical nephrectomy for pT1a renal cancer in Serbia

dc.contributor.authorJanicic, Aleksandar (6505922639)
dc.contributor.authorBumbasirevic, Uros (36990205400)
dc.contributor.authorPekomezovic, Tatjana (57193536421)
dc.contributor.authorCekerevac, Milica (18433619600)
dc.contributor.authorAcimovic, Miodrag (6508256624)
dc.contributor.authorDzamic, Zoran (6506981365)
dc.contributor.authorTulic, Cane (6602213245)
dc.date.accessioned2025-07-02T12:21:42Z
dc.date.available2025-07-02T12:21:42Z
dc.date.issued2016
dc.description.abstractPurpose: To assess the treatment outcome ofpTla renal tumors, comparing overall survival (OS) in patients treated with radical nephrectomy (RN) and partial nephrectomy (PN), and to examine the rate of utilization of PN in a tertiary institution in Serbia. Methods: Included were patients treated for pTla kidney tumors with open RN or open PN during 1996-2013. The inclusion criterion was the pathological tumor stage Tla. Exclusion criteria were higher pathological stages, metastatic presentation, or imperative indications for partial nephrectomy. Patients werefollowed-up every 3 to 4 months for the first year after surgery, every 6 months until the 5th year, and annually thereafter. Results: 286 patients were included in the study, and PN was performed in 177 (61.9%) of them, whereas RN was performed in the remaining 109 (38.1%). The median follow-up for the entire group was 42.0 months (interquartile range 74.5). There were no statistically significant differences between groups in cancer-specific survival (CSS) (log-rank=0.506; p=0.477). Patients selected for RN were more likely to be older, symptomatic at presentation, and have larger tumors. There was no statistically significant difference in OS between the two groups (log-rank=2.616; p=0.106). In 1996, 20% of the patients were treated with PN; this number increased to 88% in 2013. Conclusion: We did not find OS advantage for PN compared to RN in the setting of a developing country. The use of PN is increasing and is now utilized for -90% ofpTla renal tumors.
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85014706087&partnerID=40&md5=4a27ba5efa0963e806fc78e30bb41f50
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/13272
dc.subjectNephron-sparing surgery
dc.subjectPartial nephrectomy
dc.subjectPTla
dc.subjectRadical nephrectomy
dc.subjectSmall renal masses
dc.titlePartial versus radical nephrectomy for pT1a renal cancer in Serbia
dspace.entity.typePublication

Files